KR101884298B1 - Fermentation Method for Increasing Content of Total Phenolic Compounds and ß-Glucan with Solid Fermented Doraji, Platycodon grandiflorum, using mushroom mycelia - Google Patents
Fermentation Method for Increasing Content of Total Phenolic Compounds and ß-Glucan with Solid Fermented Doraji, Platycodon grandiflorum, using mushroom mycelia Download PDFInfo
- Publication number
- KR101884298B1 KR101884298B1 KR1020150169095A KR20150169095A KR101884298B1 KR 101884298 B1 KR101884298 B1 KR 101884298B1 KR 1020150169095 A KR1020150169095 A KR 1020150169095A KR 20150169095 A KR20150169095 A KR 20150169095A KR 101884298 B1 KR101884298 B1 KR 101884298B1
- Authority
- KR
- South Korea
- Prior art keywords
- mushroom
- fermented
- bellflower
- mycelium
- glucan
- Prior art date
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 66
- 238000000855 fermentation Methods 0.000 title claims abstract description 32
- 230000004151 fermentation Effects 0.000 title claims abstract description 32
- 244000274050 Platycodon grandiflorum Species 0.000 title claims abstract description 18
- 239000007787 solid Substances 0.000 title claims abstract description 9
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 title abstract description 19
- 229920002498 Beta-glucan Polymers 0.000 title abstract description 19
- 150000002989 phenols Chemical class 0.000 title abstract description 14
- 238000000034 method Methods 0.000 title abstract description 13
- 235000006753 Platycodon grandiflorum Nutrition 0.000 title description 8
- 235000006751 Platycodon Nutrition 0.000 claims abstract description 13
- 229930189914 platycodon Natural products 0.000 claims abstract description 13
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 12
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- 241000414067 Inonotus obliquus Species 0.000 claims abstract description 6
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 6
- 239000012138 yeast extract Substances 0.000 claims abstract description 6
- 235000001715 Lentinula edodes Nutrition 0.000 claims abstract description 5
- 238000012258 culturing Methods 0.000 claims description 4
- 239000007222 ypd medium Substances 0.000 claims description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims 1
- 239000005871 repellent Substances 0.000 claims 1
- 241000332371 Abutilon x hybridum Species 0.000 abstract description 46
- GWBIYORWNUYYMZ-UHFFFAOYSA-N platycodin D Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC(O)C(OC8CC(CO)C(O)C(O)C8O)C(CO)(CO)C7CCC6(C)C5(C)CC4O)C(O)C(O)C1OC9OCC(O)C(OC%10OCC(O)(CO)C%10O)C9O GWBIYORWNUYYMZ-UHFFFAOYSA-N 0.000 abstract description 16
- CYBWUNOAQPMRBA-NDTOZIJESA-N platycodin D Chemical compound O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CYBWUNOAQPMRBA-NDTOZIJESA-N 0.000 abstract description 16
- 229930182490 saponin Natural products 0.000 abstract description 12
- 150000007949 saponins Chemical class 0.000 abstract description 12
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract description 8
- 239000000203 mixture Substances 0.000 abstract description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 4
- 241000357613 Platycodon Species 0.000 abstract description 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 2
- 235000017709 saponins Nutrition 0.000 description 11
- 239000000284 extract Substances 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 8
- 210000000424 bronchial epithelial cell Anatomy 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 229930003935 flavonoid Natural products 0.000 description 7
- 235000017173 flavonoids Nutrition 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 240000004160 Capsicum annuum Species 0.000 description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 238000010609 cell counting kit-8 assay Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- PXQNZQURQNZGKZ-UHFFFAOYSA-N 3-O-beta-Laminaribiosyl-platycodin-D(2) Natural products OC1C(O)C(OC2C(C(OC3C(C(O)(CO)CO3)O)C(O)CO2)O)C(C)OC1OC1C(O)C(O)COC1OC(=O)C1(C(CC2(C)C3(C)CCC4C5(CO)CO)O)CCC(C)(C)CC1C2=CCC3C4(C)CC(O)C5OC(C1O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O PXQNZQURQNZGKZ-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 102100037850 Interferon gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000226211 Salminus brasiliensis Species 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 210000002821 alveolar epithelial cell Anatomy 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- PXQNZQURQNZGKZ-MXNHKPIDSA-N platycodin D2 Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PXQNZQURQNZGKZ-MXNHKPIDSA-N 0.000 description 2
- -1 polyphenol compounds Chemical class 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- AVGPOAXYRRIZMM-UHFFFAOYSA-N D-Apiose Natural products OCC(O)(CO)C(O)C=O AVGPOAXYRRIZMM-UHFFFAOYSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-LJJLCWGRSA-N D-apiofuranose Chemical group OC[C@@]1(O)COC(O)[C@@H]1O ASNHGEVAWNWCRQ-LJJLCWGRSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N D-apiofuranose Natural products OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- DFKDOZMCHOGOBR-UHFFFAOYSA-N zaragozic acid A Natural products O1C(C(O)(C(O2)C(O)=O)C(O)=O)(C(O)=O)C(OC(=O)C=CC(C)CC(C)CC)C(O)C21CCC(=C)C(OC(C)=O)C(C)CC1=CC=CC=C1 DFKDOZMCHOGOBR-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2132—Other phenolic compounds, polyphenols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5034—Beta-Glucan
Abstract
The present invention relates to a fermentation process for solidifying fermented platycodon with mushroom mycelia to increase the content of total phenolic compounds, platocidin D and betaglucan, and more particularly to a fermentation method comprising sterilizing washed platycodon, A step of inoculating a mushroom mycelium selected from Lentinula edodes KCTC 6734 and Inonotus obliquus KCTC 26147, and fermenting the mixture at a temperature of 25 ° C and a humidity of 80% by adding yeast extract to a nitrogen source, The present invention relates to a solid fermentation method of bellflower.
Platycodon fermented by mushroom mycelia of the present invention increased 1.7 to 2.5-fold and beta-glucan increased 2.5 to 32-fold, respectively, as compared to the control group in which the total phenolic compound was non-fermented. Also, the content of Platycodin D is increased in the saponin of the bellflower.
Description
In particular, the present invention relates to a method of solidifying fermented Platycodon grandiflorum with a mycelium of mushrooms, more particularly, to a method of sterilization of washed Platycodon grandiflorum, a method of sterilizing sterilized Platycodon grandiflorum, Lentinula edodes KCTC 6734 and Inonotus obliquus KCTC 26147 And a step of fermenting the yeast extract at a temperature of 25 DEG C and a humidity of 80% for 3-6 days by inoculating one mushroom mycelium with yeast extract as a nitrogen source.
delete
Platycodon grandiflorum is called aka gyungyeong (kikyou) and its scientific name is Platycodon grandiflorum. It is a native plant in Korea, China and Japan and has been used as a vegetable and perennial herb. The major component of Platycodin D is Platycodin D, and the bound sugar is a D-apiose, which is a pentose. Platycodin D is the major saponin in Platycodin D, The major pharmacological effects of these saponins include, but are not limited to, the following effects in animal experiments: intestinal damage, gonadal function, chewy nerve inhibitory action, acute chronic inflammation, anti-ulcer and gastric secretion inhibiting action, anticholinergic action to lower blood pressure by expanding blood vessels, Improvement action and the like were confirmed.
Recently, consumers are increasingly interested in functional health foods, and the demand for native perennial cultivars grown in Korea is increasing, and various processed products such as functional foods, soaps, cosmetics, and beverages are being developed. Bordeaux products are mainly marketed in the market as bordering segments, bamboo, juice, concentrate, concentrate, ring, juice, powder, etc. Recently, products utilizing bordering balloons have been gradually released.
Meanwhile, in the related art related to the present invention, Korean Patent Registration No. 1012907950000 discloses a method for preparing fermented Dorago cultivated with yeast or fermentation with yeast, wherein the content of platycodin D is increased, And a manufacturing method thereof. It was confirmed that the content of platycodine D was significantly increased in the case of culturing the pulverized bellflower with yeast isolated from the koji, fermenting with the koji, or fermenting with the koji after culturing with the yeast, compared with the general bellflower extract . Korean Patent Laid-Open Publication No. 10-2015-0042529 (Platycodon grandiflorum fermented composition having excellent anti-inflammatory and antioxidative activity and method for producing the same) shows that the fermented composition of mushroom mycelia of bellflower has excellent anti-inflammatory and antioxidative effects, As a food composition or a pharmaceutical composition for anti-inflammatory preventive treatment. In addition, Korean Patent Publication No. 1020140096771 discloses a pharmaceutical composition for preventing or treating contact dermatitis, which comprises platycodin D-containing platycodone extract as an active ingredient. Korean Patent Registration No. 1015160630000 Platycodin D-containing bellflower extract as an active ingredient Which is a cosmetic composition for skin moisturizing.
However, these prior arts have different technical constructions from those of the present invention.
Conventionally, in the fermentation of the bellflower using the mycelium of mushrooms, since the bellflower is frozen and then cooled, the mycelium is applied and fermented for one month or longer, so that the fermentation time is long and the process is complicated. Also, the fermentation of the fermented product was carried out using mycelium because the concentration of the saponin - based platycodin D or the antioxidant substance was increased. The present inventors intend to obtain a component having excellent immunoactivity and antioxidative activity by culturing the domestically produced native bellflower in domestic form using mushroom mycelium.
According to statistical data of the Ministry of Agriculture, Forestry and Livestock Foods in Korea, it is reported that the cultivation area of the platycodon in Korea is maintained at 600-700 ha. Domestic production of platycodon was 5,255 tons in 1991 but decreased gradually to 2,697 tons in 2002, but it started to increase again in 2006 and increased to 2.575 times in 2011 It is expected to last for several years.
Therefore, it is necessary to supply the functional ingredient of health food or medicinal ingredient using the active ingredient of the bellflower to make the material industrial.
The present invention relates to a method for sterilization of washed platycodon, a method of inoculating a mushroom mycelium selected from Lentinula edodes KCTC 6734 and Inonotus obliquus KCTC 26147, which is a mycelium of shiitake mushroom, and a yeast extract, % ≪ / RTI > at 25 DEG C for 3-6 days.
Platycodon pollen fermented by the mushroom mycelium of the present invention showed 200-250% increase in the total phenolic compounds of the antioxidant activity compared to the non-fermented control and 250-500% increase in the? -Glucan. Also, the content of Platycodin D is increased in the saponin of the bellflower.
Fig. 1 shows L. edodes and I. obliquus mycelium grown on a selective medium.
Fig. 2 shows the solid state of borage broth according to the inoculation of 2% to 4% of the mushroom mycelium with respect to the bellflower.
Figure 3 shows the content of saponin in the platycodon fermented by mushroom mycelium (control: autoclave (non-sterile broth). LFD: bellflower fermented with mycelium of shiitake mushroom IFD:
Fig. 4 shows the cell survival rate of A549 bronchial epithelial cells according to the treatment with mushroom fermented Dorago extract.
FIG. 5 shows IL-8 secretion inhibitory activity of A549 bronchial epithelial cells treated with mushroom fermented Dorago extract.
The present invention comprises a step of selecting mushroom mycelium seeds from a plurality of mushrooms for bellflower fermentation, a step of solidifying the bellflower using mushroom mycelium, and a step of extracting the active ingredient from the mushroom mycelium fermentation broth.
≪ Example 1 > Selection of mushroom mycelium for bellflower fermentation
Mycelia of the mushroom mycelia of Doraji fermented mushroom were selected from mycelium of shiitake mushroom KCTC6734, mycelium mushroom KCTC26147, mushroom mycelium KCTC6190, mushroom mycelium KCTC6283, mushroom mycelium KCTC16855 and mushroom mycelium KCTC26249. YPD, which is commonly used to grow fungi and yeasts including mushroom mycelium, was selected as a general growth medium for mushroom mycelia used for fermentation of the bellflower. The mushroom and mushroom mycelia grown on the YPD medium were selected and used for blooming. After 3 days of liquid culture at 25 ℃, mushrooms with good growth of mycelium were selected as the strains of Doraji fermentation.
When mushroom and mushroom mycelium were cultured at 25 ℃ for 3 days, it can be observed that YPD agar grows like a white mycelium extending around the inoculated stock (a piece of medium containing mushroom mycelium). When YPD broth was transferred to YPD broth and grown under the same conditions, it was found that the mycelium grows radially around the inoculated mycelial culture medium piece. Over time, the mycelium grows larger, and the new mycelium that grows out of it grows into another mass of mycelium, increasing its amount and volume.
≪ Example 2 > Strawberry solid fermentation using mycelium of mushroom and mushroom
The length of the section was cut to 2 ~ 3cm so that the surface area of the mushroom mycelium reached wide when the bellflower provided by the mountain village farming association was fermented. This was sterilized at 121 ° C for 20 minutes in a beaker. It was confirmed that the sterilized platycodon was more refined than the untreated platycodon, and the platycodon itself contained a lot of moisture, so that it easily disappeared by heating. In addition, the water from the bellflower is considered to have a bad effect on the quality of the water. Therefore, in the present invention, the bellflower removed from the bark provided by the manufacturer is used and washed twice or three times in a laboratory to be used in the experiment without cutting.
The mushroom mycelium cultured in the YPD broth was centrifuged and inoculated with 2% and 4% (v / W), as shown in Fig. The fermentation was conducted for 3 days at 80% humidity and 25 ° C set as initial fermentation conditions, and no change was observed on the third day of fermentation. In the YPD agar, when white mushroom mycelium was cultivated, it was observed that the white mycelium was grown. Therefore, if white mycelium is visible on the surface of the bellflower, fermentation can be confirmed. However, no mushroom mycelium was observed on the third day of fermentation, so the fermentation time was increased to 6 days, and a blue mold was bloomed. This shows that sterilization of bellflower was not properly performed with penicillin. In addition, the mushroom mycelium was not found in the bellflower because of insufficient nutrients required for growth of mycelium.
Instead of the beaker, the test material (test sieve, diameter: 7 cm, sieve size: 300 μm) was sterilized with the bellflower and used in the experiment. Sterilized at 121 DEG C for 20 minutes, cooled and sterilized again under the same conditions. As a result, unlike the previous experiment, the growth of other microorganisms such as blue mildew was not observed in addition to the mushroom mycelium, indicating that the sterilization was completely completed.
In the previous experiment, 0.002% (w / w) yeast extract was added to the mycelium at the time of inoculation, because the mushroom mycelium was not found in the fermented bellflower using the mushroom mycelium. 2% (v / W) of shiitake mushroom and mushroom mycelia were inoculated into the sterilized bellflower broth, and mushroom mycelia grew on the bellflower surface.
≪ Test Example 1 > Antioxidant content analysis of fermented Doradas
Antioxidant contents of fermented bellflower were analyzed by total phenol and total flavonoids. The pretreatment of the sample was performed by freezing and drying the frozen Doradji using the shiitake mushroom and the mushroom mycelium, and microwave and hot water extraction were performed using methanol as a solvent. This was used as a sample. Using the mycelium of shiitake mushroom, solidified fermented bellflower was heated at 50 ℃ for 24 ± α hours, dried and powdered, and extracted 3 times with distilled water for 1 hour. This was concentrated and lyophilized to prepare a sample.
≪ Analysis of total phenolic compounds >
The content of polyphenol compounds was measured by modifying the Folin-Denis method (Foloin and Denis, 1912). That is, 6 mL of distilled water was added to 0.1 mL of the extract, and 0.5 mL of folin-ciocalteu's phenol reagent was added thereto in order. After stirring, 1.5 mL of a saturated solution of Na 2 CO 3 was added, and the mixture was sufficiently stirred. After allowing to stand at room temperature for 1 hour, absorbance was measured at 765 nm (UV / VIS spectrophotometer, UV-1650PC, Shimadzu Co., Kyoto, Japan). The total phenolic compound content of the sample extract was calculated from the standard calibration curves obtained by preparing gallic acid as a standard. The fermented bellflower was frozen and dried, and methanol was extracted by microwave and heat - extraction with an extraction solvent, respectively. The fermented bellflower was used to analyze the antioxidant content of the fermented bellflower.
It can be seen that the content of total phenolic compounds is much higher than that extracted by microwave heating. The amount of the phenolic compound in the bellflower is increased by 170% to 250% by fermentation although there is a difference in the content depending on the extraction method. As the bellflower is fermented by mycelium of mushrooms, the amount of the phenolic compound, which was present as a polymer in the bellflower, is decomposed and increased.
<Total flavonoid analysis>
The analysis of flavonoid compounds was performed according to the total flavonoid test described in the Health Functional Food Cycle. That is, 1.5 mL of ethanol, 0.1 mL of 10% aluminum nitrate solution, 0.1 mL of 1 M potassium acetate solution and 2.8 mL of distilled water are added to 0.5 mL of the extract, and the mixture is sufficiently stirred. Blank tests of standard substances and samples for each concentration were made by adding 0.1 mL of distilled water instead of 10% aluminum nitrate solution. After standing at room temperature for 40 minutes, the absorbance of the liquid layer is measured at 415 nm (UV / VIS spectrophotometer, UV-1650PC, Shimadzu Co., Kyoto, Japan).
This also shows a higher total flavonoid content than the heat extracted from the microwave. The total flavonoid content of fermented bellflower showed a tendency to decrease compared to the control group, and it was found that the amount of fermented bellflower was remarkably decreased especially by using the mycelium of mushroom. It appears that fermentation completely decomposes the flavonoid material or converts it to another substance such as a phenolic compound.
<Analysis of content of saponin of fermented Doragoji>
The content of saponins in the fermented bellflower of mushroom mycelium was analyzed by Platycodin D, Platycodin D2 and Deapio-paltycodin D among the bellflower saponins. The results are shown in FIG. Platycodin D, which is the main saponin which is the pharmacological action of the bellflower, increased in both the mushroom and the mushroom mycelial fermentation. Platycodin D content was 1.2 mg / g and 1.3 mg / g, respectively, And it was confirmed that it was increased more in the mycelial fermentation broth. In addition to Platycodin D, Platycodin D2 and Deapio-paltycodin D, which are related to Platycodin D, were found to be slightly altered but not greatly differentiated. It is considered to be a strain that can produce more than bellflower saponins.
(1-3) (1-4) β-glucan and (1-3) (1-6) β-glucan analysis
The fermented bellflower was freeze-dried and pulverized into a sample. Staphylococcus aureus was sterilized twice at 121 ° C for 20 minutes as a control for fermented bellflower. (1-3) (1-4) β-glucan and (1-3) (1-6) β-glucan were analyzed using the Megazyme kit.
The content of β-glucan in the mushroom mycelia was higher than that of (1-3) (1-4) β-glucan in (1-3) (1-6) β-glucan in all the broodstock fermented with mushroom mycelia The contents of (1-3) (1-4) β-glucan and (1-3) (1-6) β-glucan in the mushroom mycelial fermentation broth were 1.7 ± 0.016% (w / (1-3) (1-4) β-glucan and (1-3) (1-6) β-glucan in the mushroom mycelial fermentation broth were 0.92 ± 0.041% (w / Were 3.5 ± 0.003% (w / w) and 1.1 ± 0.036% (w / w), respectively. (1-3) (1-4) β-glucan fermented with mushroom mycelium rather than non-fermented bellflower is about 250-500%, (1-3) (1-6) β-glucan is 270-320% And it is considered to be an increase by mycelium of mushrooms.
<IL-8 inhibitory activity of bronchial epithelial cells of fermented bell pepper>
The human bronchial epithelial cell line, type II human alveolar epithelial cell line (A549), was purchased from the Korean Cell Line Bank (Seoul, South Korea) and cultured in Dulbecco's modified Eagle's medium (DMEM) medium FBS, penicillin (10,000 U / (P / S) manufactured by Life Technologies Co. (gibco ® , Grand Island, NY, USA) was used. IL-1b, TNF-α, and IFN-γ were used to express inflammatory genes (IL-8) in A549 cell lines (BioLegend, San Diego, CA, USA). IL-8 was measured by enzyme-linked immunosorbent assay (ELISA) kit (BioLegend, USA).
Cell Culture: 80-90% under antibiotic-free DMEM medium (100 units / ㎖ penicillin, 100 ㎎ / ㎖ streptomycin) and 37 ℃ by the addition of 10% fetal bovine serum (FBS) , 5.0% CO 2 conditions confluent (3 ~ 4 days). The cells were subcultured and used for the experiment.
Measurement of IL-8 concentration by ELISA To determine the amount of IL-8 secreted in the supernatant by ELISA kit (BioLegend, USA), A549 cells (100 mm culture dish 1 x 10 5 cells / mL) After incubation for 24 hours at a concentration of 100 ng / ml each containing 100 μg / ml of TNF-α and IFN-γ and containing all samples with a cell viability exceeding 90% by CCK-8 assay, the supernatant was collected The inhibitory effect of fermented Dorado was calculated by measuring the amount of protein secretion at 450 nm or 570 nm by the IL-8 ELISA kit provided.
<IL-8 inhibitory activity of bronchial epithelial cells of fermented bell pepper>
To elucidate the anti-inflammatory effects of the mushroom fermented Doradji extract by using the type II human alveolar epithelial cell line (A549), which is a human bronchial epithelial cell line, A549 bronchial epithelial cells were isolated from the extracts by CCK-8 assay The sample throughput was determined to be 0.5 mg / mL, the highest concentration showing survival rate (FIG. 4).
The protein secretion of IL-8 in A549 bronchial epithelial cells at a concentration of 0.5 mg / mL of mushroom fermented bell pepper extract was about 9.8 ug / mL (9% reduction), slightly less than 10.1 ug / mL (7% reduction) (Fig. 5-2). As a result of the CCK-8 assay, the mushroom fermentation broth was less toxic to the cells than the raw platelets, The inflammation-inhibiting effect is considered to be large (Fig. 5).
After extracting the total phenolic compound and beta-glucan from the above-mentioned solid fermented dorado with hot water or a lower alcohol, it can be made into a food such as a beverage, a ring, a powder, a capsule, or a health functional food.
Platycodon fermented by the mushroom mycelium of the present invention showed an increase of 200-250% in total phenolic compounds and 250-500% in? -Glucan over non-fermented control. In addition, the content of Platycodin D is found to increase in the saponin of the bellflower, which is industrially applicable.
Claims (7)
(2). Culturing mycelium of Lentinula edodes KCTC 6734 and mycorrhizal mycelium Inonotus obliquus KCTC 26147 in YPD medium;
(3). 2% (v / w) of mycelium of Lentinula edodes KCTC 6734 and 2% (v / w) of Inonotus obliquus KCTC 26147, mycelia of mushroom mycelia, cultured in step (2) Adding 0.002% (w / w) of yeast extract to solid fermentation for 3-6 days at a temperature of 25 DEG C and a humidity of 80%
Wherein the solid fermentation is carried out by cultivating the sterilized platycodon in a water-repellent sieve.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150169095A KR101884298B1 (en) | 2015-11-30 | 2015-11-30 | Fermentation Method for Increasing Content of Total Phenolic Compounds and ß-Glucan with Solid Fermented Doraji, Platycodon grandiflorum, using mushroom mycelia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150169095A KR101884298B1 (en) | 2015-11-30 | 2015-11-30 | Fermentation Method for Increasing Content of Total Phenolic Compounds and ß-Glucan with Solid Fermented Doraji, Platycodon grandiflorum, using mushroom mycelia |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170063105A KR20170063105A (en) | 2017-06-08 |
KR101884298B1 true KR101884298B1 (en) | 2018-08-02 |
Family
ID=59221044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150169095A KR101884298B1 (en) | 2015-11-30 | 2015-11-30 | Fermentation Method for Increasing Content of Total Phenolic Compounds and ß-Glucan with Solid Fermented Doraji, Platycodon grandiflorum, using mushroom mycelia |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101884298B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220059611A (en) | 2020-11-03 | 2022-05-10 | 농업회사법인 주식회사 네이처포스 | Wild ginseng root by co-cultivating with ectomycorrhizal fungi and wood decay fungi and production method of the same |
KR102402408B1 (en) | 2021-05-14 | 2022-05-30 | 허서진 | Complex culture method for agaricus mushroom and multi-species mushroom mycelium |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102104214B1 (en) * | 2019-12-24 | 2020-04-23 | 오한상 | Cosmetic composition comprising potassium alum |
KR102183814B1 (en) * | 2020-05-08 | 2020-11-27 | (주)더마랩 | Preparation method of liquid culture of Lentinus edode mycelia and the liquid culture of Lentinus edode mycelia |
KR102580526B1 (en) | 2020-07-15 | 2023-09-21 | 채희원 | Method of Preparing Soybean Fermented Mycelium |
KR20230069458A (en) | 2021-11-12 | 2023-05-19 | 농업회사법인 동진식품 유한회사 | Manufacturing method to increase the efficiency of extracting three vegetables and bellflower roots |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006111820A (en) | 2004-10-18 | 2006-04-27 | Ajinomoto Co Inc | MANUFACTURING PROCESS OF beta-GLUCAN FROM FRUIT BODY OF LENTINUS EDODES |
KR100889930B1 (en) | 2008-08-27 | 2009-03-24 | 이태봉 | Method of mass-culturing inonotus obliquus and phellinus linteus using cereals or medical plants, food comprising the inonotus obliquus and the phellinus linteus cultured thereby, and method of manufacturing the food |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100919070B1 (en) * | 2007-11-15 | 2009-09-28 | 김동현 | Process for the preparation of fermentation product of esculent roots using microorganism having fermentation activity of saponin-containing esculent roots |
KR20150042529A (en) * | 2013-10-11 | 2015-04-21 | 박홍제 | Fermented ballonflower composition having excellent anti-inflammatory and anti-oxidant activity and manufacturing method thereof |
-
2015
- 2015-11-30 KR KR1020150169095A patent/KR101884298B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006111820A (en) | 2004-10-18 | 2006-04-27 | Ajinomoto Co Inc | MANUFACTURING PROCESS OF beta-GLUCAN FROM FRUIT BODY OF LENTINUS EDODES |
KR100889930B1 (en) | 2008-08-27 | 2009-03-24 | 이태봉 | Method of mass-culturing inonotus obliquus and phellinus linteus using cereals or medical plants, food comprising the inonotus obliquus and the phellinus linteus cultured thereby, and method of manufacturing the food |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220059611A (en) | 2020-11-03 | 2022-05-10 | 농업회사법인 주식회사 네이처포스 | Wild ginseng root by co-cultivating with ectomycorrhizal fungi and wood decay fungi and production method of the same |
KR102402408B1 (en) | 2021-05-14 | 2022-05-30 | 허서진 | Complex culture method for agaricus mushroom and multi-species mushroom mycelium |
Also Published As
Publication number | Publication date |
---|---|
KR20170063105A (en) | 2017-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101884298B1 (en) | Fermentation Method for Increasing Content of Total Phenolic Compounds and ß-Glucan with Solid Fermented Doraji, Platycodon grandiflorum, using mushroom mycelia | |
KR101164529B1 (en) | Ginseng fermentation system for Ginsenoside increase | |
KR101377586B1 (en) | Method for producing fermented inonotus obliquus with increased antioxidant activity and total phenolic compounds by the solid-state fermentation | |
JP6597992B2 (en) | Method for producing polyphenol-containing culture and polyphenol-containing culture | |
Sim et al. | Effect of vacuum and oven drying on the radical scavenging activity and nutritional contents of submerged fermented Maitake (Grifola frondosa) mycelia | |
KR101799400B1 (en) | Medium composition comprising amino acids for sparassis latifolia mycelium and the production method of the sparassis latifolia mycelium with improved gamma-amino butyrate using the same | |
KR101978336B1 (en) | Method for manufacturing concentrate of Aronia | |
KR102228199B1 (en) | Its Manufacturing method and Manufacturing for Pill using Moringa(Moringa oleifera) by Fermentation | |
CN105766377B (en) | A kind of cultural method improving black fungus flavones content and type | |
Kadam et al. | Fermentation and characterization of wine from dried Ficus carica (L) using Saccharomyces cerevisiae NCIM 3282 | |
KR101045011B1 (en) | Method for preparing composition comprising fermented by using of hippophae rhamnoides l | |
Khawas et al. | Banana peels and their prospects for industrial utilization | |
KR101084360B1 (en) | A rhus verniciflua stokes using mushroom its manufacture method thereof | |
KR100706696B1 (en) | Method for conversing saponins in ginsaeng | |
KR101712699B1 (en) | Method of manufacturing fermentated composition of red ginseng, and fermentated composition of red ginseng manufactured by using the same | |
KR20130008823A (en) | An improving method for antioxidant activity of extracts derived from natural herbal material and their application to cosmetic composition for the prevention of aging or medical composition for antioxidation and anti-inflammation | |
KR100464704B1 (en) | Manufacturing method of fermented alcoholic drink using medicinal and eatable plants having organic germanium and fermented alcoholic drink obtained therefrom | |
KR20120019311A (en) | Composition for immunostimulation which comprises polysaccharide from fermented ginseng with phellinus linteus to enhance the immune function | |
KR20170100965A (en) | Manufacturing Method of Fermentation Liquor of Extract from Mulberry and White Ginsing | |
KR101914866B1 (en) | Reagent Composition for Inhibiting Expression of Collagenase or MMP-1, and Method for Inhibiting Expression of Collagenase or MMP-1 | |
KR101710989B1 (en) | A new strain having acid tolerances and a method fermenting dendropanax morbifera by using same | |
KR101459541B1 (en) | Culture medium composition for Paecilomyces tenuipes including purified hemolymph from silkworm larvae and culture medium for Paecilomyces tenuipes including the same | |
KR102438729B1 (en) | Trichoderma koningii PG65 strain increasing ginsenoside content in ginseng and uses thereof | |
CN101245317A (en) | Process for producing honeysuckle flower Xanthochrous nilgheriensis (Mont.) Teng and application for medicine | |
KR20140084502A (en) | For improving liver function with aloe and Curcuma longa and A method of manufacturing the same and Using the formulations for improving liver function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |